BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/1/2014 2:50:00 PM | Browse: 1217 | Download: 1158
 |
Received |
|
2013-04-10 09:47 |
 |
Peer-Review Started |
|
2013-04-10 11:57 |
 |
To Make the First Decision |
|
2013-07-19 08:51 |
 |
Return for Revision |
|
2013-07-22 15:19 |
 |
Revised |
|
2013-08-01 23:26 |
 |
Second Decision |
|
2013-11-04 16:28 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2013-11-05 08:58 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2013-11-19 14:13 |
 |
Publish the Manuscript Online |
|
2013-12-20 16:49 |
Category |
Endocrinology & Metabolism |
Manuscript Type |
Autobiography |
Article Title |
Effect of hypolipidemic treatment on glycemic profile in patients with mixed dyslipidemia
|
Manuscript Source |
Invited Manuscript |
All Author List |
Anastazia Kei, Evangelos Liberopoulos and Moses Elisaf |
Funding Agency and Grant Number |
|
Corresponding Author |
Moses Elisaf, MD, FRSH, FASA, FISA, Professor of Internal Medicine, Department of Internal Medicine, University of Ioannina Medical School, Stavrou Niarchou Str., 45110 Ioannina, Greece. egepi@cc.uoi.gr |
Key Words |
Diabetes mellitus; Fasting plasma glucose; Fenofibrate; Insulin; Nicotinic acid/laropiprant; Rosuvastatin |
Core Tip |
In this study both addition of extended release nicotinic acid/laropiprant and switch to the highest dose of rosuvastatin deteriorated glycemic profile in patients with mixed dyslipidemia who were inadequately controlled with a standard statin dose. Add-on fenofibrate, on the other hand, seems to increase insulin sensitivity. Larger prospective studies should address the effect of these treatment interventions on new onset diabetes incidence and cardiovascular disease risk. |
Publish Date |
2013-12-20 16:49 |
Citation |
Kei A, Liberopoulos E, Elisaf M. Effect of hypolipidemic treatment on glycemic profile in patients with mixed dyslipidemia. World J Diabetes 2013; 4(6): 365-371 Available from: URL: http://www.wjgnet.com/1948-9358/full/v4/i6/365.htm DOI: http://dx.doi.org/10.4239/wjd.v4.i6.365 |
URL |
http://www.wjgnet.com/1948-9358/full/v4/i6/365.htm |
DOI |
http://dx.doi.org/10.4239/wjd.v4.i6.365 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345